Lysine methyltransferase 2C pseudogene (null)

Lysine methyltransferase 2C pseudogene (commonly annotated as KMT2CP or KMT2CP1) is a processed pseudogene derived from the lysine methyltransferase 2C (KMT2C/MLL3) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional; they typically arise from gene duplication or retrotransposition events and often lack the necessary regulatory elements or contain disabling mutations that prevent expression or function. This pseudogene is not transcribed into a functional protein and does not participate in known biological pathways or serve as a therapeutic target[1][2]. There is no evidence that the pseudogene itself has a role in disease biology, drug interaction, or clinical relevance. The Ensembl ID provided, ENSG00000279231, is not commonly associated with a functionally characterized target; it is annotated as a pseudogene, meaning it does not produce a functional protein product and is not considered a conventional drug target[1][2]. There is a potential for confusion with the protein-coding lysine methyltransferase 2C (KMT2C, also known as MLL3), which is a histone methyltransferase with important roles in chromatin modification, transcriptional regulation, and is implicated in cancer and other diseases[3][4][6][7][10][12]. However, this information does not apply to the pseudogene.

Other names

KMT2CPKMT2CP1

null